TrialDrugs in R&D2015

Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves Early-Phase Insulin Secretion in Drug-Naïve Patients with Type 2 Diabetes.

Rika Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.